Current Litigation Archives

Nuedexta: Drug Being Pushed “Off-Label” On Elderly In Nursing Homes = $116 Million Settlement

Mass Tort News Current Litigation January 7, 2020

Avanir Pharmaceuticals, the maker of Nuedexta, a prescription drug approved to treat a rare neurological condition is earning hundreds of millions of dollars a year by aggressively targeting elderly nursing home residents in “off-label” use, for whom the drug may be unnecessary and now recognized as unsafe Off-label use is when a company offers and markets a drug for reasons other than what it was initially approved for by the FDA The vast majority of the “off-label” related payments to nursing homes are coming straight from the federal government Both civil and criminal actions are often...

Big Pharma’s Opiates Have Taken A Toll On American Children

Opioid Rx Industry and a Model of “Profits Before Patients” Results: Impact on American Children In West Virginia, home of the highest overdose rates in the nation, the foster population has increased by 42 percent since 2014 The number of children in state or foster care hit a record low in Massachusetts earlier this decade Since then, that number has risen by a quarter, and there are now more children in state care than ever before In Ohio, the number of children in state custody has grown by 28 percent since 2015 Foster populations are up more than 30 percent in Alabama, Alaska,...

JUUL: How Big Tobacco bought into a company that killed teens for profit!

Mass Tort News Current Litigation , JUUL December 27, 2019

The FDA missed a deadly corporate marketing campaign–AGAIN! Juul’s popularity was fueled by the company’s social media marketing that featured attractive young people in fun, trendy settings A report by Stanford University researchers concluded that Juul’s launch marketing was “patently youth oriented” and “subsequently Juul’s principal advertising themes have been closely aligned with that of traditional tobacco advertising” Why is Juul so popular among teens Although Juul demands age verification upon navigating to its website and holds a firm stance...

FDA FINALLY MOVING ON BREAST IMPLANTS: Once again lagging behind the world in healthcare oversight

Mass Tort News Breast Implants , Current Litigation October 25, 2019

(MASS TORT NEWS) US health officials are now finally taking an assertive position regarding women getting breast implants by stating that stronger warnings and more details about the possible risks and complications including links to cancer Why has there been a multi-year FDA delay on this in the USA The Food and Drug Administration said that manufacturers should add a warning highlighted by a “black box warning” - the most serious type – to be provided to women receiving or considering implants The primary makers of breast implants approved for use in the United States include: Allergan,...

Why Does the FDA Ignore “Off-Label” Drug Marketing While Thousands Die Every Year?

Mass Tort News Current Litigation , Opioid Crisis October 19, 2019

Profits Before Patients is the FDA-Big Pharma Shared Model “BY REMOVING FDA OVERSIGHT BIG PHARMA WAS ALLOWED TO PROFIT FROM LIES” (October 19, 2019) (MASS TORT NEWS) Starting in 2017 and continuing into the foreseeable future, Big Pharma has been fighting major legal battles related to off-label marketing of drugs for unintended uses They also engaged in a parallel strategy, where they were influencing the FDA and other policy making agencies behind the scenes in Washington DC Big Pharma was paying millions to lobbyists, making campaign donations and generally buying influence as they...